Submitted by: Submitted by dannydiazion
Views: 72
Words: 1146
Pages: 5
Category: Business and Industry
Date Submitted: 11/21/2014 10:39 AM
Global Pulmonary Drug Delivery Systems Market 2015-2019
About Pulmonary Drug Delivery Systems
Pulmonary delivery of drugs leads to the deposition of drugs in the lungs and subsequent local or systemic therapeutic activity. The pulmonary route of administration for the non-invasive delivery of drugs is mostly preferred because of the large surface area for absorption, high blood circulation, and high permeability rate. Pulmonary drug delivery offers various advantages over peroral routes, such as bypass of hepatic first-pass metabolism, quick onset of action, and low enzymatic activity.
Browse Complete Report with TOC: http://www.marketresearchstore.com/report/global-pulmonary-drug-delivery-systems-market-2015-2019-1560
Pulmonary delivery of drugs can be achieved by intranasal administration or oral inhalative administration, the latter being more effective. Oral inhalative administration includes intratracheal inhalation and intratracheal instillation. Oral inhalation delivers the aerosolized drug using devices such as MDIs (or pMDIs), PDIs, and nebulizers. Drugs administered by this route are deposited in the respiratory tract via inertial impaction, gravitational sedimentation, and diffusion. The effective delivery of drugs via the pulmonary route requires an optimized combination of drug, its formulation, and device.
TechNavio's analysts forecast the Global Pulmonary Drug Delivery Systems market to grow at a CAGR of 8.90 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Pulmonary Drug Delivery Systems market for the period 2015-2019. To calculate the market size, the report considers the revenue from the sales of various pulmonary drug delivery systems intended for oral inhalation including:
Buy this Report: http://www.marketresearchstore.com/checkout/reportId/1560/reportType/0
• MDIs (or pMDIs)
• DPIs
• Nebulizers
TechNavio's report, the...